Clinical studies and animal experiments have demonstrated a crucial role of proinflammatory pathways, especially the NF-κB, IL-6/STAT3, COX-2/PGE2, and IL-23/Th17 signaling pathways, in the pathogenesis of colitis-associated CRC. This evidence concerns the gene IL6 and colitis.